What are the Challenges in Receptor-Targeted Therapy?
Despite their success, receptor-targeted therapies face several challenges. Cancer cells can develop resistance to these therapies through various mechanisms, such as secondary mutations in the receptor, activation of alternative signaling pathways, and phenotypic plasticity. Overcoming resistance requires the development of next-generation inhibitors, combination therapies, and personalized treatment approaches based on the molecular profile of the tumor.
